Albany Molecular Research Inc (NASDAQ:AMRI)
During the Trading Day
| 10.97 |  +0.06 / +0.55% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 10.96 |  -0.01 / -0.09% |
Volume: 0.00 |
Latest AMRI News | Press Releases
No recent news for Albany Molecular Research Inc.
Today’s Trading
| Previous close | 10.91 |
| Today’s open | 10.87 |
| Day’s range | 10.76 - 11.18 |
| Volume | 467,093 |
| Average volume (3 months) | 522,260 |
| Market cap | $342.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +88.89% |
| Earnings growth (this year) | +72.00% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +9.17% |
| P/E ratio | NM |
| Price/Sales | 0.71 |
| Price/Book | 1.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QLTIQLT Inc | +0.01 | +0.13% |
| DYAXDyax Corp | +0.01 | +0.40% |
| SGMOSangamo BioSciences ... | -0.03 | -0.38% |
| SGYPSynergy Pharmaceutic... | +0.09 | +1.81% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | $0.07 |
| Annual revenue (last year) | $226.7M |
| Annual profit (last year) | -$3.8M |
| Net profit margin | -1.67% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer Thomas E. D'Ambra, PhD |
Chief Financial Officer, Treasurer & VP Michael Nolan, MBA |
Corporate headquarters Albany, New York |
Forecasts
